Published in BMC Genomics on April 04, 2006
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet (2008) 4.71
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res (2009) 2.03
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry (2014) 1.59
eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull (2007) 1.57
A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics (2009) 1.50
Metabolic changes in schizophrenia and human brain evolution. Genome Biol (2008) 1.39
SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry (2010) 1.36
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology (2010) 1.30
Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry (2012) 1.27
Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull (2008) 1.10
Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics (2007) 1.07
14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol (2012) 1.05
Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry (2008) 1.00
Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis. J Neuroimmune Pharmacol (2012) 0.96
Prioritization and evaluation of depression candidate genes by combining multidimensional data resources. PLoS One (2011) 0.93
Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2009) 0.93
Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3. Biol Psychiatry (2008) 0.91
The genetic variation of RELN expression in schizophrenia and bipolar disorder. PLoS One (2011) 0.90
Gene expression analysis implicates a death receptor pathway in schizophrenia pathology. PLoS One (2012) 0.88
Differentially expressed genes in major depression reside on the periphery of resilient gene coexpression networks. Front Neurosci (2011) 0.88
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry (2009) 0.85
Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry (2014) 0.85
A comparison of four clustering methods for brain expression microarray data. BMC Bioinformatics (2008) 0.85
Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine. Schizophr Res (2009) 0.84
LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. Transl Psychiatry (2015) 0.83
An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway. J Neural Transm (Vienna) (2014) 0.80
Neurotransmission and bipolar disorder: a systematic family-based association study. Am J Med Genet B Neuropsychiatr Genet (2008) 0.79
Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition. Psychiatr Genet (2012) 0.78
Meta-analysis of sex differences in gene expression in schizophrenia. BMC Syst Biol (2016) 0.77
Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile. PLoS One (2013) 0.76
Study of five novel non-synonymous polymorphisms in human brain-expressed genes in a Colombian sample. Ann Neurosci (2014) 0.75
NERI: network-medicine based integrative approach for disease gene prioritization by relative importance. BMC Bioinformatics (2015) 0.75
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res (2003) 8.08
Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07
Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res (2004) 4.43
Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol (2001) 3.43
Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. Toxicol Sci (2002) 2.61
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol (2003) 2.52
A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics (2004) 2.21
Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20
Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods (2004) 1.26
Bayesian hierarchical error model for analysis of gene expression data. Bioinformatics (2004) 1.17
Control and variability of gene expression in mouse brain and in a neuroblastoma cell line. Rom J Physiol (2005) 0.92
The immunogenetics of smallpox vaccination. J Infect Dis (2007) 2.23
Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry (2010) 2.01
A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe? Diabetes Care (2013) 1.90
Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci U S A (2002) 1.53
Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res (2010) 1.50
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol (2008) 1.46
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med (2015) 1.22
Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One (2009) 1.19
Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry (2008) 1.00
Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int J Dev Neurosci (2010) 1.00
BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia. Mol Cancer Ther (2013) 0.97
Developmental co-regulation of the beta and gamma GABAA receptor subunits with distinct alpha subunits in the human dorsolateral prefrontal cortex. Int J Dev Neurosci (2010) 0.93
The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats. Eur J Neurosci (2004) 0.91
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study. Arthritis Res Ther (2010) 0.87
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Ann Rheum Dis (2012) 0.85
Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study. J Am Heart Assoc (2013) 0.83
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab. Ann Rheum Dis (2011) 0.82
Personalized reproductive medicine on the brink: progress, opportunities and challenges ahead. Reprod Biomed Online (2013) 0.76
Match/X, A gene expression pattern recognition algorithm used to identify genes which may be related to CDC2 function and cell cycle regulation. Cell Cycle (2004) 0.75